The effect of endostatin and radiotherapy on human lung cancer cell line A549 and the impact of HIF-1 expression after therapy

Chinese Journal of Lung Cancer

Volumn 12, Issue 1, 2009, Pages 33-37

  Zhang, Yanyan ^a   Ge, Wei ^a   Zhao, Juan ^a   Zhao, Zhenyu ^a   Li, Changhu ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cell cycle; Endostatin; HIF 1; Lung neoplasms; Radiotherapy

Indexed keywords

ENDOSTATIN; HYPOXIA INDUCIBLE FACTOR 1;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PROTEIN EXPRESSION;

EID: 60149087106     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.01.005     Document Type: Article

References (6)

1. Shi W, Teschendorf C, Muzyczka N, et al. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiother Oncol, 2003, 66(1): 1-9.
2. Wu DS, Wu CM, Huang TH, et al. Combined effects of radiotherapy and endostatin gene therapy in melanoma tumor model. Radiat Environ Biophys, 2008, 47(2): 285-291.
3. Luo X, Slater JM, Gridley DS. Enhancement of radiation effects by pX-LG-mEndo in a lung carcinoma model. Int J Radiat Oncol Biol Phys, 2005, 63(2): 553-564.
4. Yasuda S, Arii S, Mori A, et al. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol, 2004, 40(1): 117-123.
5. Harada H, Kizaka-Kondoh S, Li G, et al. Significance of HIF-1-active cells in angiogenesis and radioresistance. Oncogene, 2007, 26(54); 7508-7516.
6. Pore N, Gupta AK, Cerniglia GJ, et al. Nelfinavir down-regulates hypoxia-inducible factor 1 alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res, 2006, 66(18): 9252-9259.